In the rather small cohort of the untreated CLL patients in our study (n = 61), we did not observe any correlation between the ZAP70 mRNA expression levels in the PBMCs and the CCR1- or CCR2-positivity of the PB CD19+CD5+ lymphocytes. The gene discussed is CCR1; the disease is B-cell chronic lymphocytic leukemia.